Search: nasdaq:gild


SEARCH RESULTS FOR "NASDAQ:GILD" NEWS

Cantor Fitzgerald Issues Multiple "Strong-Buy" Ratings

Cantor Fitzgerald Issues Multiple "Strong-Buy" Ratings
80

Cantor Fitzgerald has issued "strong-buy" ratings for multiple stocks, including Immunovant, Ardelyx, Kura Oncology, and Mesoblast. Meanwhile, Bank of America adjusts price targets for Gilead Sciences and Immunovant. Read more...

MOST VIEWED

2025 Oscars: Winners, Viral Moments, and Highlights

2025 Oscars: Winners, Viral Moments, and Highlights

1687
Tech Innovations to Watch in 2025

Tech Innovations to Watch in 2025

1410
Syria Dialogue Sparks Controversy, Spy Arrested

Syria Dialogue Sparks Controversy, Spy Arrested

1375
Understanding Kid Culture and Medical Drama Escapism

Understanding Kid Culture and Medical Drama Escapism

1373